Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study

PURPOSE: Risk-stratified therapy, which modifies treatment on the basis of clinical and biologic features, has improved 5-year overall survival of childhood acute lymphoblastic leukemia (ALL) to 90%, but its impact on long-term toxicity remains unknown. METHODS: We assessed all-cause and health-rela...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Dixon, Stephanie B., Chen, Yan, Yasui, Yutaka, Pui, Ching-Hon, Hunger, Stephen P., Silverman, Lewis B., Ness, Kirsten K., Green, Daniel M., Howell, Rebecca M., Leisenring, Wendy M., Kadan-Lottick, Nina S., Krull, Kevin R., Oeffinger, Kevin C., Neglia, Joseph P., Mertens, Ann C., Hudson, Melissa M., Robison, Leslie L., Armstrong, Gregory T., Nathan, Paul C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527155/
https://ncbi.nlm.nih.gov/pubmed/32706634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00493
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados